Gilead Sciences (GILD)

R&D to Revenue

22.61%

Quarterly · Period ending:

GILD logo

GILD R&D to Revenue

Latest reported22.61%
GILD Quarterly R&D/Revenue (0.00% → 22.61%)
High-resolution chart · PNG

GILD r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences R&D to Revenue — Quarterly
Period endingR&D to Revenue
22.6067%
19.7126%
19.9899%
17.3253%
21.0563%
20.684%
21.6805%
18.4891%
19.4305%
22.7341%
19.792%
20.6667%
21.3214%
22.7802%
-15.5907%
16.3164%
17.6038%
58.8467%
27.9818%
14.8363%
17.5647%
16.4253%
21.264%
17.6068%
25.2576%
18.0966%
32.3014%
18.3797%
17.5022%
20.0151%
33.6497%
16.7798%
21.1048%
18.4159%
19.331%
12.1161%
12.0991%
14.3121%
16.5027%
15.2133%
19.0844%
16.2304%
8.8996%
8.9572%
9.9224%
9.1651%
14.2821%
10.427%
8.9365%
11.9024%
17.6926%
19.6291%
18.9312%
19.6565%
16.9865%
19.1969%
16.4746%
20.0754%
18.2803%
13.6717%
13.2134%
13.2105%
19.6509%
11.8927%
11.9896%
10.4832%
11.7914%
14.9804%
14.67%
12.3348%
14.134%
13.7145%
13.8126%
12.3436%
16.8671%
13.2562%
12.9694%
12.6494%
12.4129%
12.4617%
13.2111%
12.7584%
11.2862%
15.9752%
12.0534%
16.3642%
18.9835%
15.0846%
14.2758%
18.9388%
20.2139%
17.9566%
18.1346%
24.9175%
24.1438%
26.3748%
28.2097%
42.7897%
60.0032%
89.8124%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.